Actoplus met XR (pioglitazone and metformin HCl, extended-release) tablets, 15 m Supply Disruption — Takeda Development Center Ame
Actoplus met XR (pioglitazone and metformin HCl, extended-release) tablets, 15 m Supply Disruption — Takeda Development Center Ame is one of 9,000 drug supply records in the DrugSupply dataset. Key details — Drug name: Actoplus met XR (pioglitazone and metformin HCl, extended-release) tablets, 15 m; Manufacturer: Taked
| Drug name | Actoplus met XR (pioglitazone and metformin HCl, extended-release) tablets, 15 m |
|---|---|
| Manufacturer | Takeda Development Center Americas, Inc. |
| Recall/Disruption reason | Defective Delivery System: tablets may be missing, in whole or in part, the laser drilled holes on the metformin core of |
| Risk classification | Moderate Risk — Temporary Health Consequence |
| Status | Terminated |
| Record type | Enforcement/Recall |
| Recall number | D-0026-2019 |
| Initiation date | 20180910 |
| Quantity affected | 7,248 bottles |
| Dosage form | Drugs |
🔍 Search all drug supply records →
$1199/mo
Try DrugSupply →